Clinical Trial Update: Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and efficacy of pitavastatin in patients with metabolic syndrome and hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Metabolic Syndrome

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Hypercholesterolemia, Metabolic Syndrome | Phase 4 | Status: COMPLETED